Methods and Evaluation of Animal Models of Induced Pulmonary Hypertension

doi:10.3969/j.issn.2095-1396.2019.05.005

Abstract

Abstract:

Pulmonary hypertension is a disease developed as a result of pulmonary vascular remodeling. Its pathogenesis is not yet clear. The animal model of anoxic pulmonary hypertension was prepared，and the standardized and suitable experimental animals were selected for experiment in this paper，the existing animal models of pulmonary hypertension were described and evaluated in detail. It provides a reference for clinical research.

Key words: pulmonary, hypertension, animal model, evaluation

CLC Number:

R332，R965

ZHANG Dan-shen，LI Jia-ying. Methods and Evaluation of Animal Models of Induced Pulmonary Hypertension[J]. Acta Neuropharmacologica, DOI: 10.3969/j.issn.2095-1396.2019.05.005.

References

1 Gerald Maarman, Sandrine Lecour, Ghazwan Butrous, et al. A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?[J]. Pulmonary Circulation, 2013, 3(4): 739-756.
2 马凯, 邢泉生, 邢介龙, 等. 不同剂量野百合碱诱导大鼠肺动脉高压模型的实验研究[J]. 现代生物医学进展, 2013, 13(21): 4005-4009.
3 马凯. 野百合碱诱导大鼠肺动脉高压模型的实验研究[D].青岛：青岛大学，2013.
4 Saadia Eddahibi, Bernadette Raffestin, A C Le Monnier de Gouville. Effect of DMPPO, a pho sphodiester asetype 5 inhibitor, on hypoxic pulmonary hypertension in rats[J]. Br J Pharmacology, 1998, 125(4): 681- 688.
5 肖诗亮, 高思海, 杨辰垣. 常压缺氧性大鼠肺动脉高压模型的改进[J].临床心血管病杂志, 2001, 17(4): 190.
6 孙依萍, 杨玲, 林建海. 白果对缺氧性肺动脉高压动物模型的作用[J].中国临床医学, 2004, 11(6): 974-976.
7 Fan Jun-ming, Fan Xiao-fang, Li yang, et al. Chronic Normobaric Hypoxia Induces Pulmonary Hypertension in Rats: Role of NF-κB[J]. High Altitude Medicine & Biology, 2016, 122(1): ham.2015.0086.
8 林建海, 杨玲. 虎杖对急性缺氧性肺动脉高压的影响[J].心肺血管病杂志, 1998,17(1): 66.
9 Zhong-he Yu , Jun K , Shengxian W . Adrenomedullin and hypoxia-induced pulmonary hypertension[J]. J Chinese Tuberculosis and Respiratory Diseases, 2001, 24(3):161.
10 阮营辉, 崔华, 封志纯, 等. 急性缺氧型肺动脉高压动物模型制备[J].佛山科学技术学院学报: 自然科学版, 2007(3):27-32.
11 刘银花, 杨汉文, 王小同, 等羟胺对慢性低氧高二氧化碳大鼠肺动脉高压的影响[J]. 中国病理生理杂志, 2010, 26(11):2171-2174.
12 Kari-Otto Larsen, Ivar Sjaastad, Aud Svindland a, et al . Alveolar hypoxia induces left ventricular diastolicdys function and reduces phosphorylation of phospholamban in mice [J]. Am J Physiol Heart Circ Physio, 2006, 291(2):507-516.
13 李娟, 孙新, 毕辉, 等. 低压低氧性大鼠肺动脉高压模型的建立[J].临床心血管病杂志, 2008(04): 297-301.
14 O Pak, Almaz Aldashev, David J Weish, et al. The effects of hypoxia on the cells of the pulmonary vasculature[J].Eur Respir J, 2007, 30: 364-372.
15 李留树, 薛锋, 郭敏杰, 等. 豚鼠缺氧性肺动脉高压模型的研制[J].上海实验动物科学, 1992, 12(2):69-70.
16 陈晓辉, 翁国星, 林群. 一种新型的大鼠肺动脉高压模型[J]. 中华实验外科杂志, 2005, 22(7): 882.
17 吴东红, 王心珉, 范小芳, 等. 慢性低氧高二氧化碳性肺动脉高压大鼠肺小血管尾加压素Ⅱ表达的动态变化[J].中国微循环, 2005, 9(3):154-156.
18 Ma T T, Wang You-gan, Zhou X L, et al. Research on rat models of hypobaric hypoxia-induced pulmonary hypertension[J]. European Review for Medical & Pharmacological Sciences, 2015, 19(19):3723.
19 Anna Klinke, Annika Moller, Thorben Ravekes, et al. Protective effects of nitro-fatty acids in a hypoxia-induced murine model of pulmonary hypertension[J]. Free Radical Biology and Medicine, 2013, 65(2): S81.
20 Annaeva Wiklund, David Kylhammar, G ? ran Radegran. Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model[J]. J Cardiovascular Pharmacology, 2012, 59(5):441-449.
21 林伟, 王毅, 吴昊. 野百合碱诱导大鼠肺动脉高压模型的建立及尾加压素-Ⅱ在肺动脉高压中的表达[J].浙江实用医学, 2010, 15(02): 96-97.
22 赵永红, 苏肇伉, 张海波, 等. 脱氢野百合碱诱导犬肺动脉高压模型的建立[J]. 中华胸心血管外科杂志, 2005, 21(6):346-348.
23 Yang P S, Kim D H, Lee Y J, et al. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats[J]. Respiratory Research, 2014, 15(1):148.
24 Zhang De-xin, Wang Gui-zuo, Han Dong, et al. Activation of PPAR-γameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21WAF1: An in vivo study in rats[J]. Life Sciences, 2014, 98(1):39-43.
25 张凤伟, 吴树明, 曹广庆, 等. 颈动—静脉分流法建立肺动脉高压模型[J].山东医药, 2009, 49(51): 38-39.
26 左顺庆, 高尚志, 毛志福. 犬动力型肺动脉高压模型的建立[J].中华实验外科杂志, 1999, 16(2): 183-184.
27 周菁, 严文华, 叶文学. SD大鼠腹主动脉-下腔静脉分流术致肺动脉高压模型的建立[J].苏州大学学报: 医学版, 2005, 25(3):431-442.
28 Zhang Ming-jie, Feng Zhi-yu, Huang Rui, et al. Characteristics of pulmonary vascular remodeling in a novel model of shunt-associated pulmonary arterial hypertension[J]. Medical Science Monitor International Medical J Experimental & Clinical Research, 2018, 24:1624.
29 Jiang Y Y, He G W. Early diagnostic features of left-to-right shunt–induced pulmonary arterial hypertension in piglets[J]. The Annals of Thoracic Surgery, 2018, 106(5): 1396-1405.
30 贾一新, 李简. 慢性血栓栓塞性肺动脉高压实验动物模型的建立[J]. 中国临床康复, 2005, 9(31):119-121.
31 Philipp Ehlermann, Remppis A, Guddat O, et al. Right ventricular upregulation of the Ca(2+) binding protein S100A1in chronic pulmonary hypertension[J]. Biochim Biophys Acta, 2000, 1500(2): 249-255.
32 王海龙, 杜振宗. 慢性肺动脉栓塞实验动物模型构建的技术进展[J].中国组织工程研究与临床康复, 2010, 14(15):2818-2822.
33 Elie Fadel, Jean Yves Riou, Michel Mazmanian, et al. Pulmonary thromboendarterectomy for chronic thromboembolic obstruction of the pulmonary artery in piglets[J]. J Thorac Cardiovasc Surg, 1999, 117(4):787-793.
34 Zhang Yi-mei, Liu Wen-juan, Shi Yu-zhi, et al. Expressions of urotensin II and its receptor in pulmonary arteries in rats with chronic thromboembolic pulmonary hypertension[J]. Zhonghua Jie He He Hu Xi Za Zhi, 2008, 31(1):37-41.

[1]	ZHANG Dan-shen，ZHANG Jian-mei. Methods and Evaluation of Animal Models of Induced Pulmonary Tuberculosis [J]. Acta Neuropharmacologica, 2019, 9(6): 11-14.
[2]	ZHANG Dan-shen1，MA Jia-cheng2. Methods and Evaluation of Animal Models of Induced Pulmonary Fibrosis [J]. Acta Neuropharmacologica, 2019, 9(6): 15-20.
[3]	ZHANG Dan-shen，JIN Shan. Methods and Evaluation of Animal Models of Induced Silicosis [J]. Acta Neuropharmacologica, 2019, 9(6): 21-25.
[4]	ZHANG Dan-shen，ZHANG Jian-mei. Methods and Evaluation of Animal Models of Induced Pneumonia [J]. Acta Neuropharmacologica, 2019, 9(5): 17-23.
[5]	ZHANG Dan-shen，LI Lan. Methods and Evaluation of Animal Models of Induced Emphysema [J]. Acta Neuropharmacologica, 2019, 9(5): 30-33.
[6]	ZHANG Dan-shen，WANG Fei-fan. Methods and Evaluation of Animal Models of Induced Pulmonary Edema [J]. Acta Neuropharmacologica, 2019, 9(5): 34-39.
[7]	ZHANG Dan-shen，ZHANG Nan. Methods and Evaluation of Animal Models of Induced Bronchial Asthma [J]. Acta Neuropharmacologica, 2019, 9(4): 1-8.
[8]	SUN Cheng-cheng，LIU Jian-gang，LIU Mei-xia，LI Hao，LUO Zeng-gang. Exploration of Pathological Mechanism of Vascular Dementia Induced by Chronic Cerebral Hypoperfusion and Production of Several Common Animal Models [J]. Acta Neuropharmacologica, 2019, 9(1): 13-17.
[9]	LI Wei，ZHANG Dan-shen. Methods and Evaluation of Animal Models of Induced Chronic Bronchitis [J]. Acta Neuropharmacologica, 2019, 9(1): 18-22.
[10]	LIANG Jian-hui1,2, LIANG hui2, CHENG tao1, LIU Xiao-yan1, Simon M.Y.Lee3, TANG Ben-qin3, WANG Xiu-fen3, CHEN Feng4,Andrew J. Lawrence4. Comorbidity of Anxiety and Depression Induced by Liang’s Contextual-Stress Box in Mice* [J]. Acta Neuropharmacologica, 2018, 8(4): 44-45.
[11]	ZHANG Dan-shen，ZHANG Rui-juan. Methods and Evaluation of Animal Models of Induced Acute Respiratory Distress Syndrome [J]. Acta Neuropharmacologica, 2017, 7(6): 7-14.
[12]	LIANG Hui，CHENG Tao，LIANG Jian-hui. Progress in the Comorbidity of Depression and Anxiety [J]. Acta Neuropharmacologica, 2017, 7(6): 30-35.
[13]	WU Ya-ru，CHANG Ke-xin，JIA Qing-zhong. The Establishment and Evaluation of Animal Models of Neuropathic Pain [J]. Acta Neuropharmacologica, 2017, 7(5): 15-.
[14]	ZHANG Kuo，YANG Jing-yu，WU Chun-fu. Progress on Pathophysiology and Animal Models of Depression [J]. Acta Neuropharmacologica, 2017, 7(4): 8-16.
[15]	CAO Li-hua，BAI Ming，FANG Xiao-yan，WANG Can，MIAO Ming-san. Analysis of Animal Models of Depression Based on Clinical Symptoms [J]. Acta Neuropharmacologica, 2016, 6(4): 19-23.